搜索筛选:
搜索耗时1.7946秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[期刊论文] 作者：Ryoko Inaki,Masanobu Abe,Liang,
来源：中国癌症研究：英文版 年份：2017
Secretory carcinoma(SC), previously described as mammary analogue secretory carcinoma(MASC), is a recently described salivary gland tumor which morphologically...
[期刊论文] 作者：Masanobu Abe,Liang Zong,Takahi,
来源：中国癌症研究:英文版 年份：2018
Ameloblastoma is a benign but locally aggressive odontogenie neoplasm that accounts for 10% of all tumors arising in the mandible and maxilla (1).Eighty percent...
A Case of Pleomorphic Adenoma of the Parotid Gland with Multiple Local Recurrences through Facial to
[期刊论文] 作者：Masanobu Abe,Yoshiyuki Mori,Yu,
来源：口腔学期刊(英文) 年份：2014
Pleomorphic adenoma is the most common benign parotid gland tumor. Although its local recurrence rate is known to be high, the recurrence extending to the cervi...
[期刊论文] 作者：Ryoko Inaki,Masanobu Abe,Liang Zong,Takahiro Abe,Aya Shinozaki-Ushiku,Tetsuo Ushiku,Kazuto Hoshi,,
来源：Chinese Journal of Cancer Research 年份：2017
Secretory carcinoma(SC), previously described as mammary analogue secretory carcinoma(MASC), is a recently described salivary gland tumor which morphologically...
[期刊论文] 作者：Masanobu Abe,Liang Zong,Takahiro Abe,Hideyuki Takeshima,Jiafu Ji,Toshikazu Ushijima,Kazuto Hoshi,
来源：中国癌症研究（英文版） 年份：2018
Ameloblastoma is a benign but locally aggressive odontogenic neoplasm that accounts for 10％ of all tumors arising in the mandible and maxilla (1).Eighty percent...
Remarkably different results between two studies from North America on genomic mutations and sensiti
[期刊论文] 作者：Guiping Wang,Shanshan Guo,Huashi Xiao,Liang Zong,Tetsuya Asakawa,Masanobu Abe,Wenqing Hu,Jiafu Ji,
来源：中国癌症研究（英文版） 年份：2017
Sekeres et al.(1) conducted a multicenter randomized,controlled trial to compare whether azacitidine-based combinations with lenalidomide or vorinostat produce...
[期刊论文] 作者：Fei-Long Ning,Nan-Nan Zhang,Jun Wang,Yi-Feng Jin,Hong-Guang Quan,Jun-Peng Pei,Yan Zhao,Xian-Tao Zeng,Masanobu Abe,
来源：世界胃肠肿瘤学杂志:英文版(电子版) 年份：2021
BACKGROUND It remains controversial as to which pathological classification is most valuable in predicting the overall survival(OS)of patients with gastric cancer(GC).AIM To assess the prognostic performances of three pathological classific......
相关搜索：
